Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06467695 · ClinicalTrials.gov registry record · NA

Low Voltage Electrical Stimulation for Depression in Parkinson's Patients

A NA study, sponsored by University of South Alabama.

Recruiting
Registry status
NA
Development phase
40
Enrollment target

NCT06467695: Recruiting NA study, sponsored by University of South Alabama.

NCT06467695 is a NA study that is actively recruiting participants, run by University of South Alabama. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06467695, a NA study, is actively recruiting participants, sponsored by University of South Alabama.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

The goal of this clinical trial is to determine the relative efficacy of fMRI model guided Transcranial Direct Current Stimulation (mgTDCS) in improving the depressive symptoms of patients with Parkinson's Disease (PD). The main questions it aims to answer are: 1) Can the use of mgTDCS significantly improve the self-reported level of depression and apathy in patients with PD from pre-intervention to post-intervention compared to a sham control? 2) Can the use of mgTDCS significantly normalize the cortical eeg alpha asymmetry so commonly seen in depressed patients compared to sham mgTDCS? 3) Can the use of mgTDCS significantly improve scores on neuropsychological tests of working memory?

Interventions

  • DEVICE BIOPAC Stimsola
  • DEVICE BIOPAC Stimsola Sham (zero amps)

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-08-01
Est. Completion 2027-06-30
Phase NA

Sponsor

University of South Alabama

17 total trials

What the Registry Record Tells You About NCT06467695

The ClinicalTrials.gov registry entry for NCT06467695 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Alabama, which has 17 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which BIOPAC Stimsola is the first listed.

NCT06467695 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06467695 about?

NCT06467695 is a clinical study titled "Low Voltage Electrical Stimulation for Depression in Parkinson's Patients". The goal of this clinical trial is to determine the relative efficacy of fMRI model guided Transcranial Direct Current Stimulation (mgTDCS) in improving the depressive symptoms of patients with Parkinson's Disease (PD). The main questions it aims to answer are: 1) Can the use of mgTDCS significantly...

What is the current status of trial NCT06467695?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-08-01. Estimated completion is 2027-06-30.

What interventions are being tested in trial NCT06467695?

The interventions under investigation include: BIOPAC Stimsola (DEVICE), BIOPAC Stimsola Sham (zero amps) (DEVICE).

Who is sponsoring clinical trial NCT06467695?

This trial is sponsored by University of South Alabama, which has 17 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.